Oral presentation
Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity
08:30
A prospective, randomised, controlled trial of CPAP in adults with Down syndrome
L. Hill(Bristol, United Kingdom)
COI
1
08:45
Sleep-disordered breathing is correlated to renal impairment in patients with diabetes mellitus type 2
S. Stadler(Regensburg, Germany)
COI
2
09:00
Gout increases the risk of coronary heart disease among patients with obstructive sleep apnea: A nationwide population-based cohort study
C. Tsai(Taipei, Taiwan)
COI
3
09:15
The use of rifaximin improves sleep disorders in Hepatic Encephalopathy
M. Bruyneel(Brussels, Belgium)
COI
4
09:30
Impact of continuous positive airway pressure therapy on atrial electromechanical delay in obesity-hypoventilation syndrome patients
C. Vitale(Frattamaggiore (NA), Italy)
COI
5
09:45
Effect of patent foramen ovale closure on obstructive sleep apnea
S. Ott(Basel, Switzerland)
COI
6
10:00
Effects of co-existing asthma and OSA on objectively measured sleep and systemic inflammation
F. Sundbom(Uppsala, Sweden)
COI
7
10:15
Adaptive servoventilation (ASV) decreases unplanned hospitalisations in chronic heart failure (CHF) patients with central sleep apnoea (CSA): The French multicentre, prospective FACE cohort study
R. Tamisier(Grenoble, France)
COI
8
. . .
